In this study, researchers evaluated the performance of an artificial intelligence (AI) chatbot powered by a large language model (LLM) in providing prostate, lung, and breast cancer treatment recommendations in agreement with National Comprehensive Cancer Network (NCCN) guidelines. The results showed that the AI chatbot was able to provide accurate and reliable cancer treatment recommendations. However, the researchers noted that AI is still vulnerable to biases, limiting its applicability for medical applications.
